Black patients with kidney cancer have poorer survival than whites
Among patients with the most common form of kidney cancer, whites consistently have a survival advantage over blacks, regardless of patient and tumor characteristics or surgical treatment. That is the conclusion of a new ...
Cancer
Nov 12, 2012 |
not rated yet |
0
Renal cancer cells target of new bark-derived drug
(Medical Xpress)—Associate Professor Joe W. Ramos, PhD, a cancer biologist at the University of Hawai'i Cancer Center in collaboration with Assistant Professor William Chain, PhD, from the UH Mānoa's Chemistry Department ...
Cancer
Nov 05, 2012 |
not rated yet |
0
Stereotactic radiosurgery shows promise for kidney cancer
A first-of-its-kind clinical trial conducted at University Hospitals (UH) Case Medical Center Seidman Cancer Center has shown encouraging results for the use of stereotactic radiosurgery to treat kidney cancer. This non-invasive ...
Cancer
Oct 31, 2012 |
not rated yet |
0
Replicating risk genes in bipolar disorder
One of the biggest challenges in psychiatric genetics has been to replicate findings across large studies.
Psychology & Psychiatry
Oct 15, 2012 |
5 / 5 (3) |
0
Phase III data in treatment of renal cell carcinoma reported
New results from phase III trials exploring treatment options for patients with advanced renal cell carcinoma were released at the ESMO 2012 Congress of the European Society for Medical Oncology in Vienna.
Cancer
Oct 01, 2012 |
not rated yet |
0
Single-site laparoscopic surgery reduces pain of tumor removal
Researchers at the University of California, San Diego School of Medicine have found that recovery from an emerging, minimally invasive surgical technique called Laparo-Endoscopic Single-Site Surgery (LESS) was less painful ...
Surgery
Sep 27, 2012 |
not rated yet |
0
Possible new therapy for the treatment of myeloma
(Medical Xpress)—Research from Karolinska Institutet shows that sorafenib, a drug used for advanced cancer of the kidneys and liver, could also be effective against multiple myeloma. The disease is one of the more common ...
Cancer
Sep 05, 2012 |
not rated yet |
0
|
Afinitor approved for advanced breast cancer
(HealthDay) -- Afinitor (everolimus) has been approved in combination with the drug exemestane to treat postmenopausal women with advanced hormone-receptor positive, HER2-negative breast cancer, the U.S. Food ...
Medications
Jul 23, 2012 |
not rated yet |
0
Researchers find success with new immune approach to fighting some cancers
A national research collaboration of senior researchers, including a researcher from Moffitt Cancer Center, has found that 20 to 25 percent of "heavily pre-treated" patients with a variety of cancers who enrolled in a clinical ...
Cancer
Jun 13, 2012 |
5 / 5 (1) |
0
|
Molecular imaging signals new treatment protocol for kidney cancer
Research revealed at the Society of Nuclear Medicine's 2012 Annual Meeting explores treatment with a newly developed type of radioimmunotherapy used for treating a resistant form of kidney cancer. The agent is able to hone ...
Cancer
Jun 11, 2012 |
not rated yet |
0
New immune therapy shows promise in kidney cancer
An antibody that helps a person's own immune system battle cancer cells shows increasing promise in reducing tumors in patients with advanced kidney cancer, according to researchers at Beth Israel Deaconess Medical Center.
Cancer
Jun 04, 2012 |
not rated yet |
0
Detecting tumour cells individually
(Medical Xpress) -- Swiss researchers have devised a method to detect mutations in tumor cells that are only present in a proportion of the cancer’s cells. The analysis reveals that cells of individual ...
Cancer
May 16, 2012 |
not rated yet |
0
|
Identifying patients who benefit most from immune suppressant
A new analysis may help doctors identify breast cancer patients who will benefit from treatment with the immune suppressant drug everolimus, say French researchers at the 4th IMPAKT Breast Cancer Conference in Brussels, Belgium.
Cancer
May 03, 2012 |
5 / 5 (1) |
0
Early clinical data show galeterone safe, effective against prostate cancer
Patients with castration-resistant prostate cancer had limited side effects and in many cases a drop in prostate-specific antigen expression with galeterone (TOK-001), a small-molecule oral drug, according to phase I data ...
Cancer
Apr 01, 2012 |
5 / 5 (1) |
0
Kidney cancer subtype study finds low recurrence and cancer death rates
Patients with papillary renal cell carcinoma, the second most common kidney cancer subtype, face a low risk of tumour recurrence and cancer-related death after surgery. Those are the key findings of a multi-centre study of ...
Cancer
Mar 29, 2012 |
not rated yet |
0
